Bedrocan's Collapse Threatens Medical Marijuana Supply in the Netherlands

Bedrocan, the Netherlands' primary medical cannabis supplier, has filed for bankruptcy after losing its state contract, creating a critical crisis for pharmaceutical distribution. Thousands of patients who depend on medical marijuana for chronic pain, epilepsy, multiple sclerosis, and other conditions now face uncertain access to their prescribed treatments. The collapse threatens to destabilize Europe's most established medical cannabis program and raises urgent questions about supply chain vulnerability in regulated markets. This situation underscores the importance of robust regulatory frameworks and backup suppliers to ensure continuity of care for dependent patients.